DB
PPBT

Danske Bank’s Purple Biotech PPBT Stock Holding History

Danske Bank’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16 Buy
+4
New +$22 ﹤0.01% 1076
2024
Q4 		– Hold
0
– -$22 – 1596
2024
Q3 		– Hold
0
– – – 1498

Other funds holding PPBT

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $240M AUM
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Danske Bank's PPBT Position: Q1 2026 in Review

Danske Bank opened a new position in Purple Biotech (PPBT) in Q1 2026: 4 shares worth $16. The stake represents ﹤0.01% of the portfolio and ranks #1076 among its holdings.

15 funds tracked by Wall St. Rank hold PPBT as of Q1 2026.

  • Danske Bank held 4 shares of Purple Biotech worth $16 as of Q1 2026.
  • Purple Biotech was a new Danske Bank position in Q1 2026.
  • Purple Biotech made up ﹤0.01% of Danske Bank's portfolio in Q1 2026, its #1076 holding.
  • 15 funds tracked by Wall St. Rank held Purple Biotech as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.